open access

Vol 18, No 3 (2011)
Technology notes
Published online: 2011-06-09
Get Citation

Subcutaneous implantable cardioverter-defibrillator (S-ICD)

S. Suave Lobodzinski
Cardiol J 2011;18(3):326-331.

open access

Vol 18, No 3 (2011)
Technology notes
Published online: 2011-06-09

Abstract

Current state-of-the art implantable cardioverter-defibrillator (ICD) systems have been proven to be safe and effective in treating ventricular arrhythmias leading to cardiac death. ICDs require placement of at least one lead in, or on, the heart. Surgical placement under fluoroscopy and the ongoing presence of the transvenous leads within the patient’s heart are associated with a significant proportion of the complications related to this well-established and highly effective therapy. A new ICD has been developed that is implanted entirely subcutaneously (S-ICD), thus eliminating the need for lead placement in or on the heart and simplifying surgery by eliminating the need for imaging equipment. Recent clinical studies suggest that the S-ICD system provides a viable alternative to conventional transvenous devices that may reduce barriers to treatment and lead to the wider adoption of this life-saving therapy. (Cardiol J 2011; 18, 3: 326–331)

Abstract

Current state-of-the art implantable cardioverter-defibrillator (ICD) systems have been proven to be safe and effective in treating ventricular arrhythmias leading to cardiac death. ICDs require placement of at least one lead in, or on, the heart. Surgical placement under fluoroscopy and the ongoing presence of the transvenous leads within the patient’s heart are associated with a significant proportion of the complications related to this well-established and highly effective therapy. A new ICD has been developed that is implanted entirely subcutaneously (S-ICD), thus eliminating the need for lead placement in or on the heart and simplifying surgery by eliminating the need for imaging equipment. Recent clinical studies suggest that the S-ICD system provides a viable alternative to conventional transvenous devices that may reduce barriers to treatment and lead to the wider adoption of this life-saving therapy. (Cardiol J 2011; 18, 3: 326–331)
Get Citation

Keywords

implantable cardioverter-defibrillator; subcutaneous implantation ventricular arrythmias; subcutaneous lead electrode

About this article
Title

Subcutaneous implantable cardioverter-defibrillator (S-ICD)

Journal

Cardiology Journal

Issue

Vol 18, No 3 (2011)

Pages

326-331

Published online

2011-06-09

Bibliographic record

Cardiol J 2011;18(3):326-331.

Keywords

implantable cardioverter-defibrillator
subcutaneous implantation ventricular arrythmias
subcutaneous lead electrode

Authors

S. Suave Lobodzinski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl